Pressefach

AUSSENDER



QIAGEN N.V.
Ansprechpartner: Investor Relations
Tel.: +31 7735566 - 00
E-Mail: ir@qiagen.com
Pressefach (378)

Schlagwörter

QIAGEN N.V.
Stimmrechtsanteile
Voting rights
27.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
27.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
27.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
27.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
27.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
18.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
18.02.2026 - 22:05 | QIAGEN N.V.
Managers' transactions announcement according to article 19 MAR
11.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
11.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
11.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
11.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
06.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
06.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
06.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
06.02.2026 - 22:05 | QIAGEN N.V.
Release according to Article 40, Section 1 of the WpHG
Artikel 1 - 15
weiter
|
98.937 Abonnenten
|
231.500 Meldungen
|
93.763 Pressefotos
|
Folgen Sie uns auf  X
Top